Sign In

Login

Password

Forgot Password ? Sign Up

Prostatavergrößerung (German Wikipedia)

Analysis of information sources in references of the Wikipedia article "Prostatavergrößerung" in German language version.

refsWebsite
Global rank German rank
29nih.gov
4th place
7th place
27doi.org
2nd place
3rd place
18awmf.org
5,401st place
312th place
13google.de
2,106th place
139th place
5uroweb.org
low place
low place
2web.archive.org
1st place
1st place
2pharmazeutische-zeitung.de
8,614th place
583rd place
2wiley.com
222nd place
272nd place
1springer.com
274th place
152nd place
1arznei-telegramm.de
low place
1,888th place
1europa.eu
68th place
29th place
1redirecter.toolforge.org
33rd place
2nd place
1IABotmemento.invalid
low place
low place
1imop.gr
low place
low place
1d-nb.info
511th place
112th place
1uni-muenchen.de
3,337th place
464th place
1fda.gov
447th place
751st place
1clinicaltrials.gov
5,225th place
2,461st place
1canjurol.com
low place
low place
1zdb-katalog.de
123rd place
6th place
1jeleu.com
low place
low place

IABotmemento.invalid

  • S. Malde, A. K. Nambiar, R. Umbach, T. B. Lam, T. Bach, A. Bachmann, M. J. Drake, M. Gacci, C. Gratzke, S. Madersbacher, C. Mamoulakis, K. A. Tikkinen, S. Gravas: Systematic Review of the Performance of Noninvasive Tests in Diagnosing Bladder Outlet Obstruction in Men with Lower Urinary Tract Symptoms. In: European urology. Band 71, Nummer 3, 2017, S. 391–402, doi:10.1016/j.eururo.2016.09.026. PMID 27687821 (Review), uroweb.org (Memento des Originals vom 1. Mai 2019 im Internet Archive)  Info: Der Archivlink wurde automatisch eingesetzt und noch nicht geprüft. Bitte prüfe Original- und Archivlink gemäß Anleitung und entferne dann diesen Hinweis.@1@2Vorlage:Webachiv/IABot/uroweb.org (PDF)

arznei-telegramm.de

awmf.org

register.awmf.org

awmf.org

canjurol.com

  • H. Pham, P. Sharma: Emerging, newly-approved treatments for lower urinary tract symptoms secondary to benign prostatic hypertrophy. In: Can J Urol. Band 25, Nr. 2, 2018, S. 9228–9237, PMID 29679999 (canjurol.com [PDF]).

clinicaltrials.gov

d-nb.info

  • Karin Lehrich: Vergleich der transurethralen Holmium-Laser-Enukleation der Prostata (HoLEp) und der transvesikalen Adenomenukleation der Prostata: eine prospektive Studie. Dissertation. Freie Universität Berlin, 2002, http://d-nb.info/966392221

doi.org

  • J. M. Hollingsworth, T. J. Wilt: Lower urinary tract symptoms in men. In: BMJ. Band 349, August 2014, S. g4474, doi:10.1136/bmj.g4474. PMID 25125424, PMC 4688452 (freier Volltext) (Review).
  • Y. Gat, M. Gornish, M. Heiblum, S. Joshua: Reversal of benign prostate hyperplasia by selective occlusion of impaired venous drainage in the male reproductive system: novel mechanism, new treatment. In: Andrologia. Band 40, Nummer 5, Oktober 2008, S. 273–281, doi:10.1111/j.1439-0272.2008.00883.x. PMID 18811916.
  • M. Y. Kang, J. H. Ku, S. J. Oh: Non-invasive parameters predicting bladder outlet obstruction in Korean men with lower urinary tract symptoms. In: Journal of Korean medical science. Band 25, Nummer 2, Februar 2010, S. 272–275, doi:10.3346/jkms.2010.25.2.272. PMID 20119582. PMC 2811296 (freier Volltext).
  • J. Tacklind, R. MacDonald, I. Rutks, T. J. Wilt: Serenoa repens for benign prostatic hyperplasia. In: Cochrane database of systematic reviews (Online). Nummer 2, 2009, S. CD001423, doi:10.1002/14651858.CD001423.pub2. PMID 19370565. PMC 3090655 (freier Volltext). (Metaanalyse).
  • T. Wilt, R. Mac Donald, A. Ishani, I. Rutks, G. Stark: Cernilton for benign prostatic hyperplasia. In: Cochrane database of systematic reviews (Online). Nummer 2, 2000, S. CD001042, doi:10.1002/14651858.CD001042. PMID 10796739 (Metaanalyse).
  • J. Tacklind, H. A. Fink, R. Macdonald, I. Rutks, T. J. Wilt: Finasteride for benign prostatic hyperplasia. In: Cochrane database of systematic reviews (Online). Nummer 10, 2010, S. CD006015, doi:10.1002/14651858.CD006015.pub3. PMID 20927745. (Metaanalyse).
  • Mauro Gacci, Giovanni Corona, Matteo Salvi, Linda Vignozzi, Kevin T. McVary, Steven A. Kaplan, Claus G. Roehrborn, Sergio Serni, Vincenzo Mirone, Marco Carini, Mario Maggi: A systematic review and meta-analysis on the use of phosphodiesterase 5 inhibitors alone or in combination with α-blockers for lower urinary tract symptoms due to benign prostatic hyperplasia. In: European Urology. Band 61, 2012, doi:10.1016/j.eururo.2012.02.033.
  • Roderick MacDonald, Michelle Brasure, Philipp Dahm, Carin M. Olson, Victoria A. Nelson, Howard A. Fink, Michael C. Risk, Bruce Rwabasonga, Timothy J. Wilt: Efficacy of newer medications for lower urinary tract symptoms attributed to benign prostatic hyperplasia: a systematic review. In: The Aging Male. Band 1, 2019, doi:10.1080/13685538.2018.1434503.
  • Fabiola Zakia Mónica, Gilberto De Nucci: Tadalafil for the treatment of benign prostatic hyperplasia. In: Expert Opinion on Pharmacotherapy. Band 8, 2019, doi:10.1080/14656566.2019.1589452.
  • Y. H. Jiang, H. C. Kuo: Recent research on the role of urodynamic study in the diagnosis and treatment of male lower urinary tract symptoms and urinary incontinence. In: Ci ji yi xue za zhi = Tzu-chi medical journal. Band 29, Nummer 2, Apr-Jun 2017, S. 72–78, doi:10.4103/tcmj.tcmj_19_17. PMID 28757770, PMC 5509199 (freier Volltext) (Review).
  • S. Malde, A. K. Nambiar, R. Umbach, T. B. Lam, T. Bach, A. Bachmann, M. J. Drake, M. Gacci, C. Gratzke, S. Madersbacher, C. Mamoulakis, K. A. Tikkinen, S. Gravas: Systematic Review of the Performance of Noninvasive Tests in Diagnosing Bladder Outlet Obstruction in Men with Lower Urinary Tract Symptoms. In: European urology. Band 71, Nummer 3, 2017, S. 391–402, doi:10.1016/j.eururo.2016.09.026. PMID 27687821 (Review), uroweb.org (Memento des Originals vom 1. Mai 2019 im Internet Archive)  Info: Der Archivlink wurde automatisch eingesetzt und noch nicht geprüft. Bitte prüfe Original- und Archivlink gemäß Anleitung und entferne dann diesen Hinweis.@1@2Vorlage:Webachiv/IABot/uroweb.org (PDF)
  • G. Losco, L. Keedle, Q. King: Non-invasive urodynamics predicts outcome prior to surgery for prostatic obstruction. In: BJU international. Band 112 Suppl 2, November 2013, S. 61–64, doi:10.1111/bju.12382. PMID 24127677, (PDF)
  • R. S. Eapen, S. B. Radomski: Review of the epidemiology of overactive bladder. In: Research and reports in urology. Band 8, 2016, S. 71–76, doi:10.2147/RRU.S102441. PMID 27350947, PMC 4902138 (freier Volltext) (Review).
  • A. W. Thomas, P. Abrams: Lower urinary tract symptoms, benign prostatic obstruction and the overactive bladder. In: BJU international, Band 85 Suppl 3, Mai 2000, S. 57–68. PMID 11954200 (Review), doi:10.1111/j.1464-410X.2000.tb16953.x, wiley.com (PDF)
  • O. Reich: Benignes Prostatasyndrom. In: Der Urologe A. Volume 49, Nr. 1, 2010, S. 113–126, doi:10.1007/s00120-009-2183-1.
  • J. N. Cornu, S. Ahyai, A. Bachmann, J. de la Rosette, P. Gilling, C. Gratzke, K. McVary, G. Novara, H. Woo, S. Madersbacher: A Systematic Review and Meta-analysis of Functional Outcomes and Complications Following Transurethral Procedures for Lower Urinary Tract Symptoms Resulting from Benign Prostatic Obstruction: An Update. In: European urology. Band 67, Nummer 6, Juni 2015, S. 1066–1096, doi:10.1016/j.eururo.2014.06.017. PMID 24972732 (Review), imop.gr (PDF; 1,7 MB)
  • H. E. Foster, M. J. Barry, P. Dahm, M. C. Gandhi, S. A. Kaplan, T. S Kohler u. a.: Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline. In: J Urol. Band 200, Nr. 3, 2018, S. 612–619, doi:10.1016/j.juro.2018.05.048, PMID 29775639.
  • Blessing Dhliwayo, Saheel Mukhtar: Novel Surgical Treatments for Benign Prostatic Hyperplasia. In: Journal of Endoluminal Endourology. Band 2, Nr. 1, 31. Januar 2019, ISSN 2561-9187, S. e17–e23, doi:10.22374/jeleu.v2i1.29., (PDF)
  • E. C. Hwang, J. H. Jung, M. Borofsky, M. H. Kim, P. Dahm: Aquablation of the prostate for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia. In: Cochrane Database Syst Rev. Band 2, 2019, S. CD013143, doi:10.1002/14651858.CD013143.pub2, PMID 30759311, PMC 6373984 (freier Volltext).
  • H. Saadat, D. S. Elterman: The Role of Aquablation for the Surgical Treatment of LUTS/BPH. In: Curr Urol Rep. Band 20, Nr. 8, 2019, S. 46, doi:10.1007/s11934-019-0905-5, PMID 31227924.
  • K. C. Zorn, S. L. Goldenberg, R. Paterson, A. So, D. Elterman, N. Bhojani: Aquablation among novice users in Canada: A WATER II subpopulation analysis. In: Can Urol Assoc J. Band 13, Nr. 5, 2019, S. E113-E118, doi:10.5489/cuaj.5501, PMID 30332589, PMC 6520060 (freier Volltext).
  • J. C. Ulchaker, M. S. Martinson: Cost-effectiveness analysis of six therapies for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia. In: ClinicoEconomics and outcomes research: CEOR. Band 10, 2018, S. 29–43, doi:10.2147/CEOR.S148195. PMID 29343977, PMC 5749396 (freier Volltext).
  • K. T. McVary, T. Rogers, C. G. Roehrborn: Rezūm Water Vapor Thermal Therapy for Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia: 4-Year Results From Randomized Controlled Study. In: Urology, Band 126, 04 2019, S. 171–179, doi:10.1016/j.urology.2018.12.041. PMID 30677455 (freier Volltext).
  • J. Y. Leong, A. S. Patel, R. Ramasamy: Minimizing Sexual Dysfunction in BPH Surgery. In: Current sexual health reports. Band 11, Nummer 3, September 2019, S. 190–200, doi:10.1007/s11930-019-00210-1. PMID 31467497, PMC 6714584 (freier Volltext) (Review).
  • K. T. McVary, T. Rogers, J. Mahon, N. K. Gupta: Is Sexual Function Better Preserved After Water Vapor Thermal Therapy or Medical Therapy for Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia? In: The journal of sexual medicine. Band 15, Nummer 12, Dezember 2018, S. 1728–1738, doi:10.1016/j.jsxm.2018.10.006. PMID 30446471.
  • J. Westwood, R. Geraghty, P. Jones, B. P. Rai, B. K. Somani: Rezum: a new transurethral water vapour therapy for benign prostatic hyperplasia. In: Therapeutic advances in urology. Band 10, Nummer 11, November 2018, S. 327–333, doi:10.1177/1756287218793084. PMID 30344644, PMC 6180381 (freier Volltext) (Review).
  • J. K. Parsons, A. V. Sarma, K. McVary, J. T. Wei: Obesity and benign prostatic hyperplasia: clinical connections, emerging etiological paradigms and future directions. In: The Journal of Urology 182, 2009, S. S2 7–S3 1, doi:10.1016/j.juro.2009.07.086. PMID 19846130. (Review).

europa.eu

ema.europa.eu

  • Assessment Report Cialis, Committee for Medicinal Products for Human Use (CHMP), 18. Oktober 2012 ema.europa.eu (PDF; 1,3 MB)

fda.gov

google.de

books.google.de

imop.gr

  • J. N. Cornu, S. Ahyai, A. Bachmann, J. de la Rosette, P. Gilling, C. Gratzke, K. McVary, G. Novara, H. Woo, S. Madersbacher: A Systematic Review and Meta-analysis of Functional Outcomes and Complications Following Transurethral Procedures for Lower Urinary Tract Symptoms Resulting from Benign Prostatic Obstruction: An Update. In: European urology. Band 67, Nummer 6, Juni 2015, S. 1066–1096, doi:10.1016/j.eururo.2014.06.017. PMID 24972732 (Review), imop.gr (PDF; 1,7 MB)

jeleu.com

  • Blessing Dhliwayo, Saheel Mukhtar: Novel Surgical Treatments for Benign Prostatic Hyperplasia. In: Journal of Endoluminal Endourology. Band 2, Nr. 1, 31. Januar 2019, ISSN 2561-9187, S. e17–e23, doi:10.22374/jeleu.v2i1.29., (PDF)

nih.gov

ncbi.nlm.nih.gov

  • R. T. Chang, R. Kirby, B. J. Challacombe: Is there a link between BPH and prostate cancer? In: The Practitioner. Band 256, Nummer 1750, April 2012, S. 13–6, 2. PMID 22792684.
  • J. M. Hollingsworth, T. J. Wilt: Lower urinary tract symptoms in men. In: BMJ. Band 349, August 2014, S. g4474, doi:10.1136/bmj.g4474. PMID 25125424, PMC 4688452 (freier Volltext) (Review).
  • Y. Gat, M. Gornish, M. Heiblum, S. Joshua: Reversal of benign prostate hyperplasia by selective occlusion of impaired venous drainage in the male reproductive system: novel mechanism, new treatment. In: Andrologia. Band 40, Nummer 5, Oktober 2008, S. 273–281, doi:10.1111/j.1439-0272.2008.00883.x. PMID 18811916.
  • M. Y. Kang, J. H. Ku, S. J. Oh: Non-invasive parameters predicting bladder outlet obstruction in Korean men with lower urinary tract symptoms. In: Journal of Korean medical science. Band 25, Nummer 2, Februar 2010, S. 272–275, doi:10.3346/jkms.2010.25.2.272. PMID 20119582. PMC 2811296 (freier Volltext).
  • J. Tacklind, R. MacDonald, I. Rutks, T. J. Wilt: Serenoa repens for benign prostatic hyperplasia. In: Cochrane database of systematic reviews (Online). Nummer 2, 2009, S. CD001423, doi:10.1002/14651858.CD001423.pub2. PMID 19370565. PMC 3090655 (freier Volltext). (Metaanalyse).
  • T. Wilt, R. Mac Donald, A. Ishani, I. Rutks, G. Stark: Cernilton for benign prostatic hyperplasia. In: Cochrane database of systematic reviews (Online). Nummer 2, 2000, S. CD001042, doi:10.1002/14651858.CD001042. PMID 10796739 (Metaanalyse).
  • J. Tacklind, H. A. Fink, R. Macdonald, I. Rutks, T. J. Wilt: Finasteride for benign prostatic hyperplasia. In: Cochrane database of systematic reviews (Online). Nummer 10, 2010, S. CD006015, doi:10.1002/14651858.CD006015.pub3. PMID 20927745. (Metaanalyse).
  • A. M. Arisco, E. K. Brantly, S. R. Kraus: Oxybutynin extended release for the management of overactive bladder: a clinical review. In: Drug Design, Development and Therapy. Band 3, 2009, S. 151–161. PMID 19920931. PMC 2769230 (freier Volltext).
  • Y. H. Jiang, H. C. Kuo: Recent research on the role of urodynamic study in the diagnosis and treatment of male lower urinary tract symptoms and urinary incontinence. In: Ci ji yi xue za zhi = Tzu-chi medical journal. Band 29, Nummer 2, Apr-Jun 2017, S. 72–78, doi:10.4103/tcmj.tcmj_19_17. PMID 28757770, PMC 5509199 (freier Volltext) (Review).
  • S. Malde, A. K. Nambiar, R. Umbach, T. B. Lam, T. Bach, A. Bachmann, M. J. Drake, M. Gacci, C. Gratzke, S. Madersbacher, C. Mamoulakis, K. A. Tikkinen, S. Gravas: Systematic Review of the Performance of Noninvasive Tests in Diagnosing Bladder Outlet Obstruction in Men with Lower Urinary Tract Symptoms. In: European urology. Band 71, Nummer 3, 2017, S. 391–402, doi:10.1016/j.eururo.2016.09.026. PMID 27687821 (Review), uroweb.org (Memento des Originals vom 1. Mai 2019 im Internet Archive)  Info: Der Archivlink wurde automatisch eingesetzt und noch nicht geprüft. Bitte prüfe Original- und Archivlink gemäß Anleitung und entferne dann diesen Hinweis.@1@2Vorlage:Webachiv/IABot/uroweb.org (PDF)
  • G. Losco, L. Keedle, Q. King: Non-invasive urodynamics predicts outcome prior to surgery for prostatic obstruction. In: BJU international. Band 112 Suppl 2, November 2013, S. 61–64, doi:10.1111/bju.12382. PMID 24127677, (PDF)
  • R. S. Eapen, S. B. Radomski: Review of the epidemiology of overactive bladder. In: Research and reports in urology. Band 8, 2016, S. 71–76, doi:10.2147/RRU.S102441. PMID 27350947, PMC 4902138 (freier Volltext) (Review).
  • A. W. Thomas, P. Abrams: Lower urinary tract symptoms, benign prostatic obstruction and the overactive bladder. In: BJU international, Band 85 Suppl 3, Mai 2000, S. 57–68. PMID 11954200 (Review), doi:10.1111/j.1464-410X.2000.tb16953.x, wiley.com (PDF)
  • J. N. Cornu, S. Ahyai, A. Bachmann, J. de la Rosette, P. Gilling, C. Gratzke, K. McVary, G. Novara, H. Woo, S. Madersbacher: A Systematic Review and Meta-analysis of Functional Outcomes and Complications Following Transurethral Procedures for Lower Urinary Tract Symptoms Resulting from Benign Prostatic Obstruction: An Update. In: European urology. Band 67, Nummer 6, Juni 2015, S. 1066–1096, doi:10.1016/j.eururo.2014.06.017. PMID 24972732 (Review), imop.gr (PDF; 1,7 MB)
  • J. Michalak, D. Tzou, J. Funk: : HoLEP: the gold standard for the surgical management of BPH in the 21(st) Century. In: American journal of clinical and experimental urology. Band 3, Nr. 1, 2015, S. 36–42, PMID 26069886.
  • T. F. Aho: Holmium laser enucleation of the prostate: a paradigm shift in benign prostatic hyperplasia surgery. In: Ther Adv Urol. Band 5, Nr. 5, Oct 2013, S. 245–253. PMID 24082919.
  • H. E. Foster, M. J. Barry, P. Dahm, M. C. Gandhi, S. A. Kaplan, T. S Kohler u. a.: Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline. In: J Urol. Band 200, Nr. 3, 2018, S. 612–619, doi:10.1016/j.juro.2018.05.048, PMID 29775639.
  • H. Pham, P. Sharma: Emerging, newly-approved treatments for lower urinary tract symptoms secondary to benign prostatic hypertrophy. In: Can J Urol. Band 25, Nr. 2, 2018, S. 9228–9237, PMID 29679999 (canjurol.com [PDF]).
  • E. C. Hwang, J. H. Jung, M. Borofsky, M. H. Kim, P. Dahm: Aquablation of the prostate for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia. In: Cochrane Database Syst Rev. Band 2, 2019, S. CD013143, doi:10.1002/14651858.CD013143.pub2, PMID 30759311, PMC 6373984 (freier Volltext).
  • H. Saadat, D. S. Elterman: The Role of Aquablation for the Surgical Treatment of LUTS/BPH. In: Curr Urol Rep. Band 20, Nr. 8, 2019, S. 46, doi:10.1007/s11934-019-0905-5, PMID 31227924.
  • K. C. Zorn, S. L. Goldenberg, R. Paterson, A. So, D. Elterman, N. Bhojani: Aquablation among novice users in Canada: A WATER II subpopulation analysis. In: Can Urol Assoc J. Band 13, Nr. 5, 2019, S. E113-E118, doi:10.5489/cuaj.5501, PMID 30332589, PMC 6520060 (freier Volltext).
  • J. C. Ulchaker, M. S. Martinson: Cost-effectiveness analysis of six therapies for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia. In: ClinicoEconomics and outcomes research: CEOR. Band 10, 2018, S. 29–43, doi:10.2147/CEOR.S148195. PMID 29343977, PMC 5749396 (freier Volltext).
  • K. T. McVary, T. Rogers, C. G. Roehrborn: Rezūm Water Vapor Thermal Therapy for Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia: 4-Year Results From Randomized Controlled Study. In: Urology, Band 126, 04 2019, S. 171–179, doi:10.1016/j.urology.2018.12.041. PMID 30677455 (freier Volltext).
  • J. Y. Leong, A. S. Patel, R. Ramasamy: Minimizing Sexual Dysfunction in BPH Surgery. In: Current sexual health reports. Band 11, Nummer 3, September 2019, S. 190–200, doi:10.1007/s11930-019-00210-1. PMID 31467497, PMC 6714584 (freier Volltext) (Review).
  • K. T. McVary, T. Rogers, J. Mahon, N. K. Gupta: Is Sexual Function Better Preserved After Water Vapor Thermal Therapy or Medical Therapy for Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia? In: The journal of sexual medicine. Band 15, Nummer 12, Dezember 2018, S. 1728–1738, doi:10.1016/j.jsxm.2018.10.006. PMID 30446471.
  • J. Westwood, R. Geraghty, P. Jones, B. P. Rai, B. K. Somani: Rezum: a new transurethral water vapour therapy for benign prostatic hyperplasia. In: Therapeutic advances in urology. Band 10, Nummer 11, November 2018, S. 327–333, doi:10.1177/1756287218793084. PMID 30344644, PMC 6180381 (freier Volltext) (Review).
  • J. K. Parsons, A. V. Sarma, K. McVary, J. T. Wei: Obesity and benign prostatic hyperplasia: clinical connections, emerging etiological paradigms and future directions. In: The Journal of Urology 182, 2009, S. S2 7–S3 1, doi:10.1016/j.juro.2009.07.086. PMID 19846130. (Review).
  • E. A. Platz, E. B. Rimm, I. Kawachi, G. A. Colditz, M. J. Stampfer, W. C. Willett, E. Giovannucci: Alcohol consumption, cigarette smoking, and risk of benign prostatic hyperplasia. In: American journal of epidemiology. Band 149, Nummer 2, Januar 1999, S. 106–115. PMID 9921955.
  • J. Sea, K. S. Poon, K. T. McVary: Review of exercise and the risk of benign prostatic hyperplasia. In: The Physician and sportsmedicine. Band 37, Nummer 4, Dezember 2009, S. 75–83. PMID 20048544.

pharmazeutische-zeitung.de

redirecter.toolforge.org

  • S. Malde, A. K. Nambiar, R. Umbach, T. B. Lam, T. Bach, A. Bachmann, M. J. Drake, M. Gacci, C. Gratzke, S. Madersbacher, C. Mamoulakis, K. A. Tikkinen, S. Gravas: Systematic Review of the Performance of Noninvasive Tests in Diagnosing Bladder Outlet Obstruction in Men with Lower Urinary Tract Symptoms. In: European urology. Band 71, Nummer 3, 2017, S. 391–402, doi:10.1016/j.eururo.2016.09.026. PMID 27687821 (Review), uroweb.org (Memento des Originals vom 1. Mai 2019 im Internet Archive)  Info: Der Archivlink wurde automatisch eingesetzt und noch nicht geprüft. Bitte prüfe Original- und Archivlink gemäß Anleitung und entferne dann diesen Hinweis.@1@2Vorlage:Webachiv/IABot/uroweb.org (PDF)

springer.com

link.springer.com

uni-muenchen.de

klinikum.uni-muenchen.de

uroweb.org

web.archive.org

  • D. Pfeiffer u. a.: HIFU-Technik zur primären interventionellen Behandlung des Prostatakarzinoms – Frühergebnisse. In: Hamburger Ärzteblatt. 5/2006, S. 277 pdf (Memento vom 12. Dezember 2010 im Internet Archive)
  • S. Malde, A. K. Nambiar, R. Umbach, T. B. Lam, T. Bach, A. Bachmann, M. J. Drake, M. Gacci, C. Gratzke, S. Madersbacher, C. Mamoulakis, K. A. Tikkinen, S. Gravas: Systematic Review of the Performance of Noninvasive Tests in Diagnosing Bladder Outlet Obstruction in Men with Lower Urinary Tract Symptoms. In: European urology. Band 71, Nummer 3, 2017, S. 391–402, doi:10.1016/j.eururo.2016.09.026. PMID 27687821 (Review), uroweb.org (Memento des Originals vom 1. Mai 2019 im Internet Archive)  Info: Der Archivlink wurde automatisch eingesetzt und noch nicht geprüft. Bitte prüfe Original- und Archivlink gemäß Anleitung und entferne dann diesen Hinweis.@1@2Vorlage:Webachiv/IABot/uroweb.org (PDF)

wiley.com

onlinelibrary.wiley.com

zdb-katalog.de

  • Blessing Dhliwayo, Saheel Mukhtar: Novel Surgical Treatments for Benign Prostatic Hyperplasia. In: Journal of Endoluminal Endourology. Band 2, Nr. 1, 31. Januar 2019, ISSN 2561-9187, S. e17–e23, doi:10.22374/jeleu.v2i1.29., (PDF)